Acro Biomedical (ACBM) Net Income towards Common Stockholders Growth (1y) (2017 - 2026)
Powered by 
Analysis
Acro Biomedical (ACBM) Net Income towards Common Stockholders Growth (1y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | -6.99% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 8.57% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | -36.56% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 84.38% |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 985.71% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | -153.86% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | -52.92% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | -12.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.80% |
| Dec 31, 2025 | 3,660.41% |
| Sep 30, 2025 | -1,051.72% |
| Jun 30, 2025 | -53.43% |
| Mar 31, 2025 | 8.45% |
| Dec 31, 2024 | -100.10% |
| Sep 30, 2024 | 99.36% |
| Jun 30, 2024 | 99.68% |
| Mar 31, 2024 | 99.72% |
| Dec 31, 2023 | 146.54% |
| Sep 30, 2023 | 60.37% |
| Jun 30, 2023 | 20.05% |
| Mar 31, 2023 | -1.92% |
| Dec 31, 2022 | -75.95% |
| Sep 30, 2022 | -34.12% |
| Jun 30, 2022 | -402.92% |
| Mar 31, 2022 | -6,503.69% |
| Sep 30, 2021 | -4,207.01% |
| Jun 30, 2021 | -1,147.57% |
| Mar 31, 2021 | -173.34% |